Clinical trial
SELUTION™ Sirolimus Coated PTA Balloon Catheter Prospective, Controlled, Multi-Center, Open, Single-Arm Clinical Investigation for the Treatment of Patients With Femoropopliteal Artery Lesions With a Novel Drug Coated Balloon
NCT02941224 is registered in ClinicalTrials.gov with M.A. Med Alliance S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SELUTION™ Sirolimus Coated PTA Balloon Catheter Prospective, Controlled, Multi-Center, Open, Single-Arm Clinical Investigation for the Treatment of Patients With Femoropopliteal Artery Lesions With a Novel Drug Coated Balloon
- Lead sponsor
- M.A. Med Alliance S.A.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- September 30, 2019
- Enrollment
- 50 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
patients with peripheral artery disease in the sfa or pa